- Markets
- Healthcare
- OMKARPH
OMKARPH
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
(In Cr.) |
---|
(In Cr.) | ||||
---|---|---|---|---|
This data is currently unavailable for this company. |
(In %) |
---|
(In Cr.) |
---|
Financial Year (In Cr.) |
---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
Omkar Pharmachem Re-Appoints Bhawani Shankar Goyal As MD
Sept 3 (Reuters) - Omkar Pharmachem Ltd OMKR.BO:
OMKAR PHARMACHEM - RE-APPOINTS BHAWANI SHANKAR GOYAL AS MD
Source text for Eikon: ID:nBSE84kZVF
Further company coverage: OMKR.BO
(([email protected];;))
Sept 3 (Reuters) - Omkar Pharmachem Ltd OMKR.BO:
OMKAR PHARMACHEM - RE-APPOINTS BHAWANI SHANKAR GOYAL AS MD
Source text for Eikon: ID:nBSE84kZVF
Further company coverage: OMKR.BO
(([email protected];;))
Events:
More Micro Cap Ideas
See similar 'Micro' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Omkar Pharmachem do?
Omkar Pharmachem Ltd specializes in manufacturing pharmaceutical chemicals such as sodium bi-sulphite, sodium meta bi-sulphite, sodium sulphite, and sulphur.
Who are the competitors of Omkar Pharmachem?
Omkar Pharmachem major competitors are Vineet Laboratories, Concord Drugs, Veerhealth Care, Guj. Inject (Kerala), Kabra Drugs, Zenith Health Care, Unick Fix-A-Form. Market Cap of Omkar Pharmachem is ₹30 Crs. While the median market cap of its peers are ₹31 Crs.
Is Omkar Pharmachem financially stable compared to its competitors?
Omkar Pharmachem seems to be financially stable compared to its competitors. The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
Does Omkar Pharmachem pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Omkar Pharmachem latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Omkar Pharmachem allocated its funds?
Companies resources are majorly tied in miscellaneous assets
How strong is Omkar Pharmachem balance sheet?
Balance sheet of Omkar Pharmachem is strong. But short term working capital might become an issue for this company.
Is the profitablity of Omkar Pharmachem improving?
The profit is oscillating. The profit of Omkar Pharmachem is ₹0.19 Crs for Mar 2024, ₹0.2 Crs for Mar 2023 and ₹0.18 Crs for Mar 2022
Is the debt of Omkar Pharmachem increasing or decreasing?
The debt of Omkar Pharmachem is decreasing. Latest debt of Omkar Pharmachem is ₹0.12 Crs as of Sep-24. This is less than Mar-24 when it was ₹0.16 Crs.
Is Omkar Pharmachem stock expensive?
Yes, Omkar Pharmachem is expensive. Latest PE of Omkar Pharmachem is 160, while 3 year average PE is 123. Also latest EV/EBITDA of Omkar Pharmachem is 101 while 3yr average is 82.14.
Has the share price of Omkar Pharmachem grown faster than its competition?
Omkar Pharmachem has given lower returns compared to its competitors. Omkar Pharmachem has grown at ~12.04% over the last 2yrs while peers have grown at a median rate of 20.27%
Is the promoter bullish about Omkar Pharmachem?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Omkar Pharmachem is 0.03% and last quarter promoter holding is 0.03%.
Are mutual funds buying/selling Omkar Pharmachem?
There is Insufficient data to gauge this.